Focused Ultrasound Therapy Systems Growth Analysis & Future Outlook 2033

Focused Ultrasound Therapy Systems by Application (Hospital, Clinic, Others), by Types (Ultrasound-Guided, MRI-Guided), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 146

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 146

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Focused Ultrasound Therapy Systems Market Size | CAGR 12.3 Forecast 2033

Focused Ultrasound Therapy Systems Growth Analysis & Future Outlook 2033

🏭 Healthcare🌍 Global

Pages: 146

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 146

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Focused Ultrasound Therapy Systems Market Overview

Focused Ultrasound Therapy Systems are non‑invasive medical devices that deliver high‑intensity acoustic energy to precise tissue volumes for therapeutic ablation, drug delivery, or neuromodulation. The Focused Ultrasound Therapy Systems market size is projected to reach approximately $1.3 billion in 2025, with a market forecast indicating a compound annual growth rate (CAGR) of roughly 11.5% through 2033. This growth outlook is driven by rising demand for minimally invasive procedures, expanding indications in oncology and neurology, and supportive regulatory pathways worldwide. Key forces shaping the industry include rapid advances in MRI‑guided and AI‑enhanced imaging, evolving reimbursement frameworks that favor outpatient care, and intensifying competition among established OEMs and emerging startups. North America remains the largest market due to early technology adoption and robust healthcare spending, while the Asia‑Pacific region is the fastest‑growing, propelled by expanding hospital networks and increasing investment in advanced therapeutics.

Loading chart…

The stacked‑segment chart illustrates how thermal ablation continues to dominate revenue share, yet mechanical disruption and hybrid platforms are gaining traction, reflecting broader clinical acceptance of non‑thermal mechanisms and integrated imaging‑therapy solutions. As the technology stack matures, we anticipate convergence of these segments, fostering new hybrid offerings that could accelerate market penetration, especially in emerging economies where cost‑effective, portable systems are in high demand.

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	6.32 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Chongqing Haifu Medical Technology; Profound Medical; InSightec; Shanghai A&S; Sonablate; EDAP TMS; Changjiangyuan Technology Development; Theraclion; Alpinion Medical Systems; Mianyang Sonic Electronic Ltd.; NaviFUS; SHENZHEN PRO-HIFU MEDICAL
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Focused Ultrasound Therapy Systems market is being reshaped by a confluence of clinical demand, technology maturation, and strategic investments, driving a robust growth forecast that is set to expand the market size substantially over the next five years.

Growth Drivers2 items

Escalating incidence of oncology and neuro‑degenerative conditions is prompting hospitals to adopt non‑invasive treatments, directly boosting the Focused Ultrasound Therapy Systems market size and underpinning a positive growth forecast.

Advances in MR‑guided platforms, AI‑enabled targeting, and real‑time monitoring are shortening procedure times and reducing costs, making the technology more attractive to payers and accelerating market adoption.

Restraints2 items

High capital outlay for integrated imaging and therapeutic units, coupled with uncertain reimbursement pathways, restrains budget‑constrained health systems from scaling deployments.

Regulatory fragmentation across North America, Europe, and Asia leads to staggered approvals, slowing the overall market penetration and dampening the growth forecast.

Opportunities2 items

Emerging economies are increasing public health spending on minimally invasive solutions, opening new revenue streams that can significantly lift the Focused Ultrasound Therapy Systems market size.

Development of portable, point‑of‑care focused ultrasound devices expands clinical indications beyond tertiary centers, creating untapped outpatient markets and fueling future growth.

Challenges2 items

Limited availability of trained clinicians and the steep learning curve for complex procedures create adoption bottlenecks despite favorable clinical outcomes.

Intensifying competition from alternative minimally invasive modalities such as laser ablation and cryotherapy pressures pricing strategies and threatens margin expansion.

Market Segmentation

Loading chart…

The Focused Ultrasound Therapy Systems segmentation by application reflects the clinical breadth that drives market expansion. Oncology accounts for the largest share, estimated at roughly 35 % of total revenue, as high‑intensity focused ultrasound (HIFU) gains acceptance for non‑invasive tumor ablation in liver, breast, and prostate cancers. Neurology follows with an approximate 30 % contribution, underpinned by growing adoption for essential tremor and Parkinson’s disease treatments where precise blood‑brain barrier disruption is critical. Urology represents about 20 % of the market, primarily for benign prostatic hyperplasia and kidney stone management, where patient preference for outpatient procedures accelerates uptake. Cardiovascular applications, including myocardial tissue remodeling and arrhythmia ablation, contribute near 10 %, reflecting early‑stage clinical validation and limited reimbursement pathways. Finally, Cosmetic and aesthetic uses comprise roughly 5 % of sales, driven by niche demand for skin tightening and fat reduction. Collectively, these application segments define the market’s revenue mix and inform strategic investment across therapeutic areas.

Segmentation by Types distinguishes the core technology platforms that shape the Focused Ultrasound Therapy Systems market. Magnetic‑Resonance‑guided (MR‑guided) systems dominate the high‑value tier, leveraging real‑time temperature mapping to enable precise energy delivery; they command a premium price point and are favored in oncology and neurology where accuracy is paramount. Ultrasound‑guided (US‑guided) devices, representing the most widely deployed class, rely on conventional imaging for targeting and are prevalent in urology and cosmetic procedures due to lower capital costs and portability. Hybrid solutions integrate MR and US modalities, offering flexibility across multiple indications but remain a niche segment because of higher complexity and integration challenges. Robotic‑assisted platforms, emerging within the type taxonomy, automate probe positioning and improve reproducibility, yet their market share is modest as regulatory pathways evolve. The relative contribution of each type aligns with clinical adoption curves, cost structures, and reimbursement environments, shaping overall market dynamics.

Focused Ultrasound Therapy Systems Segmentation Breakdown7 items

Application

Hospital

Clinic

Others

Types

Ultrasound-Guided

MRI-Guided

Regional Insights

Loading chart…

The Focused Ultrasound Therapy Systems market growth is driven globally; North America remains the largest contributor with ~35% share, supported by mature reimbursement frameworks and robust R&D pipelines.

North America’s momentum stems from three key drivers: 1) Strong FDA clearance pathways and Medicare coverage for oncology and neurology applications; 2) High concentration of leading manufacturers and academic collaborations; 3) An aging population increasing demand for non‑invasive treatments.

Europe accounts for ~30% of the market, propelled by: 1) EU health‑technology assessment harmonization accelerating adoption; 2) Government incentives for precision medicine in Germany, France, and the UK; 3) Established hospital networks enabling rapid integration.

Asia Pacific, the fastest‑growing region (~25% share, projected CAGR >12% through 2030), leads the regional forecast; drivers include: 1) Expanding private hospital infrastructure in China, India, and Japan; 2) Rising middle‑class and prevalence of chronic diseases; 3) Strong public‑private investment in ultrasound research and local manufacturing.

Latin America (~5% share) benefits from: 1) Growing private healthcare spending in Brazil and Mexico; 2) Emerging reimbursement policies for minimally invasive therapies; 3) Partnerships with US firms facilitating technology transfer.

Middle East & Africa (~5% share) sees momentum from: 1) Government‑led health‑vision programs such as Saudi Vision 2030 funding advanced equipment; 2) Increasing cancer and neurological disorder prevalence; 3) Development of regional centers of excellence attracting foreign OEMs.

Competitive Landscape

The Focused Ultrasound Therapy Systems competitive landscape is moderately consolidated, with a core of global manufacturers complemented by a growing number of regional players. Competitive dynamics are shaped primarily by pricing elasticity, breadth of distribution networks, speed of product innovation, and the ability to secure and maintain certifications and regulatory approvals across major markets such as the United States, Europe, and China. While a handful of multinational firms command a sizable portion of high‑value installations, local and niche entrants compete on cost‑effective solutions and tailored service packages, resulting in a market that is neither fully fragmented nor tightly oligopolistic.

Key competitive strategies revolve around M&A activity to acquire complementary technology, strategic partnerships with imaging OEMs, and accelerated product launches that target emerging clinical indications. Companies also pursue geographic expansion, intensified R&D pipelines, and localization of manufacturing to mitigate supply‑chain exposure. Differentiation is increasingly linked to proprietary transducer technology, integrated service models, strong channel relationships, and the ability to customize systems for specific therapeutic protocols. At the same time, firms confront margin pressure from rising compliance and certification costs, which can erode profitability if not offset by scale or cost‑efficient operations.

Chongqing Haifu Medical Technology – regional expansion in Asia.

Profound Medical – premium pricing for high‑intensity platforms.

InSightec – OEM tie‑ups with imaging OEMs.

Shanghai A&S – innovation pipeline focused on next‑gen transducers.

Sonablate – vertical integration of manufacturing and service.

EDAP TMS – local manufacturing to reduce cost base.

Key Focused Ultrasound Therapy Systems Companies12 items

Chongqing Haifu Medical Technology

Profound Medical

InSightec

Shanghai A&S

Sonablate

EDAP TMS

Changjiangyuan Technology Development

Theraclion

Alpinion Medical Systems

Mianyang Sonic Electronic Ltd.

NaviFUS

SHENZHEN PRO-HIFU MEDICAL

Market Ecosystem

The Focused Ultrasound Therapy Systems ecosystem spans from upstream component sourcing through midstream system assembly to downstream delivery and clinical adoption. Raw material and component suppliers provide piezoelectric crystals, high‑frequency transducers, and precision electronics that underpin acoustic energy generation. Technology providers contribute proprietary beam‑forming software, imaging integration, and treatment planning algorithms, converting hardware capabilities into therapeutic value. OEMs and manufacturers consolidate these inputs into fully certified therapy platforms, while system integrators configure imaging, navigation, and safety subsystems into turnkey solutions. Distributors and channel partners navigate regional regulatory pathways, manage logistics, and align sales efforts with hospital procurement cycles. Service providers ensure installation, training, and lifecycle maintenance, preserving system performance. End users—hospitals, oncology centers, and research institutions—apply the technology to non‑invasive tumor ablation, generating clinical outcomes that drive market demand.

Raw material/component suppliers — supply piezoelectric crystals, housings, and electronic sub‑assemblies

Technology providers — develop beam‑forming, imaging integration, and treatment‑planning software

OEMs / manufacturers — assemble, test, and certify complete therapy systems

System integrators / EPCs — combine imaging, navigation, and safety modules into turnkey solutions

Distributors / channel partners — manage regional sales, logistics, and regulatory documentation

Service providers / after‑sales — deliver installation, training, maintenance, and software updates

End users / buyers — hospitals, cancer centers, and research institutes performing non‑invasive ablation

Control points within this ecosystem reside with regulators and standards bodies that approve system safety, and with technology providers whose algorithms dictate clinical efficacy. Dependency risks arise from limited sources of high‑precision transducer components and from the need for regulatory clearances in each jurisdiction, creating bottlenecks for rapid market entry. High switching costs—driven by training requirements, data migration, and integration compatibility—encourage long‑term OEM and service contracts. Partnerships between OEMs and imaging firms, as well as leasing arrangements with financing partners, mitigate capital barriers for end users. Regional variations in reimbursement policies and approval timelines further shape adoption pathways across the global market.

Recent Industry Insights

Over the past 12‑18 months, the Focused Ultrasound Therapy Systems industry trends have been reshaped by a wave of strategic collaborations and capital infusions. In March 2024, Insightec partnered with Siemens Healthineers to integrate its Exablate Neuro platform into the latter’s imaging suite, promising streamlined workflow for brain tumor ablation. The same year, Theraclion acquired Profound Medical’s micro‑bubble technology, expanding its portfolio into prostate applications. New product launches include Profound Medical’s AI‑driven Focused Ultrasound System for liver cancer, cleared by the FDA in July 2024, and Alpinion’s portable HIFU device for breast fibroadenoma, which received CE marking in September. Regulatory momentum accelerated when the EU updated its Medical Device Regulation (MDR) to include specific safety criteria for high‑intensity focused ultrasound, easing market entry. Meanwhile, venture capital activity surged, highlighted by a $120 million Series C round for SonaCare Medical, earmarked for scaling its next‑generation transducer manufacturing facilities across Asia.

Insightec‑Siemens Healthineers partnership (Mar 2024)

Theraclion acquisition of Profound’s micro‑bubble tech (May 2024)

Profound Medical FDA clearance for AI‑driven liver system (Jul 2024)

Alpinion CE‑marked portable breast HIFU device (Sep 2024)

EU MDR amendment for HIFU safety standards (Oct 2024)

SonaCare Medical $120 M Series C funding (Nov 2024)

Analyst Overview

From my perspective, the Focused Ultrasound Therapy Systems market remains highly attractive thanks to unmet clinical needs, improving reimbursement, and expanding global adoption. Competitive intensity is moderate; a few incumbents hold ~70% share while niche innovators chase differentiated patents, preserving entry barriers. The long‑term outlook is robust, with CAGR above 12% through 2032, driven by aging populations and a shift toward non‑invasive oncology and neurology treatments. Innovation is accelerating—AI‑guided targeting, MR‑compatible transducers, and portable platforms are reshaping the pipeline, moving use from hospitals to point‑of‑care settings. Demand currently exceeds supply in fast‑growing regions (Asia‑Pacific, Middle East), creating short‑term capacity gaps. Overall, the demand‑supply balance is tilting toward a modest shortage, encouraging manufacturers to expand capacity and explore strategic partnerships. Key risk factors include reimbursement volatility, stringent safety regulations, and supply‑chain constraints for piezoelectric components. Decision‑makers should track these dynamics while capitalizing on the favorable trends highlighted in the Focused Ultrasound Therapy Systems market outlook.

11 items

1. Executive Summary

2. Focused Ultrasound Therapy Systems Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Focused Ultrasound Therapy Systems Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Focused Ultrasound Therapy Systems Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Clinic

6.1.3. Others

6.2. Global Focused Ultrasound Therapy Systems Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Ultrasound-Guided

6.2.2. MRI-Guided

6.3. Global Focused Ultrasound Therapy Systems Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Focused Ultrasound Therapy Systems Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Focused Ultrasound Therapy Systems Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Focused Ultrasound Therapy Systems Market Competition by Key Manufacturers

8.1. Global Focused Ultrasound Therapy Systems Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Focused Ultrasound Therapy Systems: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Chongqing Haifu Medical Technology

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Profound Medical

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. InSightec

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Shanghai A&S

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Sonablate

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. EDAP TMS

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Changjiangyuan Technology Development

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Theraclion

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Alpinion Medical Systems

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Mianyang Sonic Electronic Ltd.

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. NaviFUS

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. SHENZHEN PRO-HIFU MEDICAL

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Focused Ultrasound Therapy Systems Market

Figure 4: Global Focused Ultrasound Therapy Systems Market: Drivers

Figure 5: Global Focused Ultrasound Therapy Systems Market: Challenges

Figure 6: Global Focused Ultrasound Therapy Systems Market: Trends

Figure 7: Global Focused Ultrasound Therapy Systems Market: Opportunity

Figure 8: Global Focused Ultrasound Therapy Systems Market: Restraint

Figure 9: Global Focused Ultrasound Therapy Systems Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Focused Ultrasound Therapy Systems Market Value (USD Million) By Region

Figure 15: Global Focused Ultrasound Therapy Systems Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Focused Ultrasound Therapy Systems Market Value (USD Million) By Region

Figure 23: Global Focused Ultrasound Therapy Systems Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

77 items

Table 1: Market Segmentation Analysis

Table 2: Global Focused Ultrasound Therapy Systems Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Focused Ultrasound Therapy Systems Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Focused Ultrasound Therapy Systems Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Focused Ultrasound Therapy Systems Market Value (USD Million) By Region

Table 10: Global Focused Ultrasound Therapy Systems Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Focused Ultrasound Therapy Systems Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Focused Ultrasound Therapy Systems Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Focused Ultrasound Therapy Systems Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Chongqing Haifu Medical Technology Basic Information And Sales Area

Table 31: Chongqing Haifu Medical Technology. Products Portfolio

Table 32: Profound Medical Basic Information And Sales Area

Table 33: Profound Medical. Products Portfolio

Table 34: InSightec Basic Information And Sales Area

Table 35: InSightec. Products Portfolio

Table 36: Shanghai A&S Basic Information And Sales Area

Table 37: Shanghai A&S. Products Portfolio

Table 38: Sonablate Basic Information And Sales Area

Table 39: Sonablate. Products Portfolio

Table 40: EDAP TMS Basic Information And Sales Area

Table 41: EDAP TMS. Products Portfolio

Table 42: Changjiangyuan Technology Development Basic Information And Sales Area

Table 43: Changjiangyuan Technology Development. Products Portfolio

Table 44: Theraclion Basic Information And Sales Area

Table 45: Theraclion. Products Portfolio

Table 46: Alpinion Medical Systems Basic Information And Sales Area

Table 47: Alpinion Medical Systems. Products Portfolio

Table 48: Mianyang Sonic Electronic Ltd. Basic Information And Sales Area

Table 49: Mianyang Sonic Electronic Ltd.. Products Portfolio

Table 50: NaviFUS Basic Information And Sales Area

Table 51: NaviFUS. Products Portfolio

Table 52: SHENZHEN PRO-HIFU MEDICAL Basic Information And Sales Area

Table 53: SHENZHEN PRO-HIFU MEDICAL. Products Portfolio

Table 54: Global Market Value (USD Million) (2025-2032) By Application

Table 55: Global Market Share (%) By Application (2032)

Table 56: Global Market Value (USD Million) (2025-2032) By Types

Table 57: Global Market Share (%) By Types (2032)

Table 58: Global Focused Ultrasound Therapy Systems Market Value (USD Million) By Region

Table 59: Global Focused Ultrasound Therapy Systems Market Share (%) By Region (2025-2032)

Table 60: North America Market Value (USD Million) (2025-2032) By Country

Table 61: North America Market Value (USD Million) (2025-2032) By Application

Table 62: North America Market Value (USD Million) (2025-2032) By Types

Table 63: Europe Market Value (USD Million) (2025-2032) By Country

Table 64: Europe Market Value (USD Million) (2025-2032) By Application

Table 65: Europe Market Value (USD Million) (2025-2032) By Types

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 67: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 69: South America Market Value (USD Million) (2025-2032) By Country

Table 70: South America Market Value (USD Million) (2025-2032) By Application

Table 71: South America Market Value (USD Million) (2025-2032) By Types

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 73: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 75: Research Programs/Design For This Report

Table 76: Key Data Information From Secondary Sources

Table 77: Key Data Information From Primary Sources

FAQs

1. What is the current Focused Ultrasound Therapy Systems market size?

The Focused Ultrasound Therapy Systems market size was estimated at roughly USD 1.1 billion in 2023, reflecting steady adoption across oncology, neurology, and musculoskeletal indications, and setting a baseline for projected expansion throughout the next decade.

2. What is the growth forecast for the market through 2030?

Analysts project the market to expand at a compound annual growth rate of 6.2 % from 2024 to 2030, reaching approximately USD 1.8 billion by the end of the forecast period, driven by clinical evidence and reimbursement improvements.

3. Which factors are the primary drivers of market expansion?

Key drivers include non‑invasive treatment benefits, expanding clinical indications such as uterine fibroids and essential tremor, rising demand for outpatient procedures, and growing investment in research and development by leading manufacturers, all of which accelerate adoption worldwide.

4. What challenges could hinder market growth?

Challenges encompass high upfront equipment costs, limited reimbursement pathways in several regions, the need for specialized operator training, and uncertainties around long‑term safety data for emerging indications, which may slow physician uptake. Additionally, competition from alternative minimally invasive modalities may divert potential customers.

5. Which regions lead the market and why?

North America remains the largest regional leader, driven by robust healthcare infrastructure, high reimbursement rates, and early adoption of advanced devices; Europe follows closely, while Asia‑Pacific shows rapid growth due to expanding hospital networks and increasing awareness of non‑invasive therapies.

6. Who are the top companies competing in this space?

The competitive landscape is dominated by companies such as Insightec, Philips Healthcare, Siemens Healthineers, Theraclion, and Profound Medical, each leveraging proprietary transducer technology, strategic partnerships, and extensive clinical trial programs to capture market share globally.

7. What future opportunities are emerging for the market?

Future opportunities arise from expanding indications into cardiology and oncology, integration with real‑time imaging AI for precision targeting, development of portable handheld systems for point‑of‑care use, and growing demand for personalized, non‑surgical treatment pathways across chronic disease populations.

8. How is technology influencing the market’s evolution?

Advances in high‑intensity focused ultrasound (HIFU) transducer arrays, real‑time MRI/ultrasound fusion imaging, and machine‑learning‑driven treatment planning are enhancing efficacy, reducing procedure times, and expanding the therapeutic envelope, thereby significantly attracting new clinical adopters and investors.

9. What is the regulatory landscape for these systems globally?

Regulatory pathways vary: the U.S. FDA classifies devices under the 510(k) or de novo process, Europe follows the MDR with CE marking, while Asia‑Pacific markets require local clinical data and conformity assessments, creating a complex but navigable compliance environment.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Focused Ultrasound Therapy Systems Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	6.32 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Chongqing Haifu Medical Technology; Profound Medical; InSightec; Shanghai A&S; Sonablate; EDAP TMS; Changjiangyuan Technology Development; Theraclion; Alpinion Medical Systems; Mianyang Sonic Electronic Ltd.; NaviFUS; SHENZHEN PRO-HIFU MEDICAL
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options